Plasma micrornas as novel biomarkers for early detection of lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 6, 2011, Pages 575-586

  Zheng, Dali ^a,b   Haddadin, Shadi ^c   Wang, Yong ^d   Gu, Li Qun ^d   Perry, Michael C ^c   Freter, Carl E ^c   Wang, Michael X ^a  

^a University of Missouri   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Early diagnosis; Lung cancer; Metastasis; Plasma microrna; Prognosis; Real time RT PCR

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; DNA MICROARRAY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; LUNG CARCINOMA; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BRONCHOGENIC; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80055051965     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics 2011, The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.
2. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007;297: 953-961.
3. National Lung Screening Trial Research Team. The National Lung Screening Trial overview and study design. Radiology 2011;258:243-253.
4. The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low -Dose Computed Tomographic Screening. N Engl J Med. 2011 Jun 29.
5. Barba M, Felsani A, Rinaldi M, Giunta S, Malorni W, Paggi MG. Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology. J Cell Physiol. 2011;226:2213-2214.
6. Garzon R, Calin GA, and Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009;60:167-179.
7. Davalos V and Esteller M. MicroRNAs and cancer epigenetics: a macroevolution. Curr Opin Oncol 2010;22:35-45.
8. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
9. Xie Y, Todd NW, Liu Z, Zhan M, Fang H. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010;67:170-176.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-10518.
11. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102:1174-1179.
12. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-126.
13. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
14. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007;13:1668-1674.
15. Shi R, Chiang VL. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 2005;39:519-525.
16. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33: e179.
17. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
19. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9: 189-198.
20. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RTPCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008;14: 844-852.
21. Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 2008; 27:3845-3855.
22. Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009;45:2197-2206.
23. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009;69:5776-5783.
24. Miko E, Czimmerer Z, Csánky E, Boros G, Buslig J et al. Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009;35:646-664.
25. Hu Z, Chen X, Zhao Y, Tian T, Jin G et al. Serum microRNA signatures identified in a genomewide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-1726.
26. Ferracin M, Veronese A, Negrini M. Micromarkers miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010;10:297-308.
27. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009;9:703-711.
28. Wang QZ, Xu W, Habib N, Xu R. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 2009; 9:572-594.
29. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2011;91:579-587.
30. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009;10: 42-46.
31. Tili E, Croce CM, Michaille JJ. miR-155 on the crosstalk between inflammation and cancer. Int Rev Immunol 2009;28:264-284.
32. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009;1792:497-505.
33. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010;126:73-80.
34. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26153.
35. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008;105:7004-7009.